MedTrace Logo

Maxillary Sinus Elevation With Bio-Oss or Straumann BoneCeramic

NCT00901121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2016-03-03

No results posted yet for this study

Summary

The purpose of the study was to test a clinically relevant non-inferiority of Straumann BoneCeramic treatment compared to Bio-Oss treatment 180 to 240 days after sinus grafting procedure.

Conditions

  • Teeth Loss
  • Bone Loss

Interventions

DEVICE

Straumann BoneCeramic

Straumann BoneCeramic (500-1000 microns, 0.5g)

DEVICE

Bio-Oss

Bio-Oss spongiosa granules, size of particle 0.25-1 mm

Sponsors & Collaborators

  • Institut Straumann AG

    lead INDUSTRY

Principal Investigators

  • Matteo Chiapasco, Prof · University of Milan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2007-04-30
Completion
2011-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901121 on ClinicalTrials.gov